Allisartan isoproxil/amlodipine in hypertension with microalbuminuria or hyperuricemia

Phase 4, open-label trial of allisartan isoproxil and amlodipine in essential hypertension (2 arms), sponsored by Chengdu Wenjiang District People's Hospital. Primary endpoint: Mean change from baseline in sitting office systolic and diastolic blood pressure at Week 24. Planned start Sep 2026; status: not yet recruiting.